NDC 72162-1735-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1735
- Requested NDC
- 72162-1735-01
- Package NDCs from labels
- 72162-1735-1, 72162-1735-2, 72162-1735-3, 72162-1735-4, 72162-1735-5, 72162-1735-6, 72162-1735-7, 72162-1735-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-09-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-09-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1735-1 | Acyclovir | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | 102 | |
| 72162-1735-2 | Acyclovir | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 102 | |
| 72162-1735-3 | Acyclovir | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 102 | |
| 72162-1735-4 | Acyclovir | 28 in 1 BOTTLE, PLASTIC | TABLET | 28 | 102 | |
| 72162-1735-5 | Acyclovir | 10 in 1 BOTTLE, PLASTIC | TABLET | 10 | 102 | |
| 72162-1735-6 | Acyclovir | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 102 | |
| 72162-1735-7 | Acyclovir | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 102 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1735 | ACYCLOVIR TABLET [BRYANT RANCH PREPACK] | 102 | Current NDC, 7 package rows | 20240919_f09cdb3f-dfd2-4e47-bb5e-a5d26d8bcc89.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1735-1 | EA - Each | 72162-1735 | bf807b4a-bf13-47b0-92f0-62c6bc84e4db | 1 | 2023-10-16 |
| 72162-1735-2 | EA - Each | 72162-1735 | 999a483e-5326-4ee8-87e6-8fd123c683a9 | 1 | 2023-10-16 |
| 72162-1735-3 | EA - Each | 72162-1735 | 38ad4994-e407-46b8-9f2b-ed6e1e7914bc | 1 | 2023-10-16 |
| 72162-1735-4 | EA - Each | 72162-1735 | 60b855ee-7970-4008-a5fb-103c4ae7ea3a | 1 | 2023-10-16 |
| 72162-1735-5 | EA - Each | 72162-1735 | 44fa26cf-3c82-408f-a845-49cec7cb696a | 1 | 2023-10-16 |
| 72162-1735-6 | EA - Each | 72162-1735 | b231becf-f4b5-4705-8b28-6f8972065e5c | 1 | 2023-10-16 |
| 72162-1735-7 | EA - Each | 72162-1735 | a8a2b11d-7516-4dab-bb64-cf00cb211cf7 | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | f6f56143-ea74-af87-e053-6394a90ae346 | 2026-01-01 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | ff9776b3-a248-e1ea-e053-6294a90aeb7b | 2026-01-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | YILING PHARMACEUTICAL, INC. | 67e7b340-0635-2595-e053-2a91aa0ad266 | 2025-12-30 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | YILING PHARMACEUTICAL, INC. | 8542495c-eef1-448b-abb5-83cb1ac589f7 | 2025-12-30 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | YILING PHARMACEUTICAL, INC. | 677edfd5-2d04-b932-e053-2a91aa0a26b0 | 2025-12-30 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Acyclovir | ACYCLOVIR | Chartwell Governmental & Specialty RX, LLC. | 2757bb30-3374-4e1b-b496-14874f7ec623 | 2025-12-23 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Chartwell RX, LLC | 7d2a75a5-233f-46dd-9cb0-3918ea53e554 | 2025-12-18 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Aurobindo Pharma Limited | cfee4476-a3c9-4e0c-a235-c68c5d46931e | 2025-12-16 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Redpharm Drug | 37453bcd-e34e-5902-e063-6294a90a0245 | 2025-12-13 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Chartwell RX, LLC | 8cd22728-34b4-4e55-8339-580138fe46d8 | 2025-12-09 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Cadila Pharmaceuticals Limited | acef88f4-6456-4092-993f-27e1496097c7 | 2025-12-05 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Aurobindo Pharma Limited | 37761c4f-4378-472e-a41b-6a1d40575cb7 | 2025-12-03 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Viona Pharmaceuticals Inc | e580b7e9-9060-43f5-9b58-33998078d7e4 | 2025-12-02 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Advagen Pharma Limited | 6a9ea291-4ad5-48a8-8c08-5a17c8757549 | 2025-11-27 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | 8d9fea43-6c04-40d7-8aac-398c2de2a558 | 2025-11-27 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Zydus Pharmaceuticals (USA) Inc. | edb0cd28-ee57-4b60-be94-62c797fbf5e6 | 2025-11-27 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | 395cd839-21e1-43e2-a8ce-078f07bc7668 | 2025-11-22 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Apotex Corp. | 7fdeb609-24c4-5024-52c3-6a32bc7f3fcc | 2025-11-20 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Apotex Corp. | 41bea43a-f58c-2c6f-4d31-406ceb456077 | 2025-11-17 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.